Hetal Vachhani, MD
Hematology & Oncology · Richmond, VANPI 1295945764
Payments from drug & device makers
Across 13 payments — averaging $10,873 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$141K
- Gilead$46
- Boston Scientific$39
- Pfizer$31
- Daiichi Sankyo Inc.$17
- Conmed Corporation$15
- plus $11 from 1 others
What the payments were for
- Food & beverage$11773%
- Education$4327%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 5 | $141,187 |
| Gilead | 2 | $46 |
| Boston Scientific | 2 | $39 |
| Pfizer | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Conmed Corporation | 1 | $15 |
| Merit Medical Systems Inc | 1 | $11 |
How this compares
$141,347 in reported general payments places this provider in the 75th percentile of 293 hematology & oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 68 | $1,417 |
| Exemestane | 11 | $1,230 |
| Ondansetron Hcl | 19 | $858 |
| Letrozole | 23 | $710 |
| Tamoxifen Citrate | 15 | $484 |
| Prochlorperazine Maleate | 14 | $193 |
| Alendronate Sodium | 18 | $128 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Richmond
- Erin AlesiRichmond$1.7M
- Sarah GordonRichmond$1M
- Will VoelzkeRichmond$774K
- James KhatcheressianRichmond$773K
- Victor YazbeckRichmond$756K
- William ClarkRichmond$685K
- Elke FriedmanRichmond$571K
- Joshua McFarlaneRichmond$390K
- Jonathan BerkmanRichmond$360K
- Reed MitchellRichmond$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.